AI News
AI companies run virtual drug trials, aim to improve success of human studies
Simulated patient trials aim to bridge the gap between lab research and clinical success.
Read the full story at Reuters TechnologyRT
Reuters Technology
Source
Reuters Technology

AI Analysis
Generated insight by OnAirToday AI
Virtual drug trials leverage generative models to simulate patient responses, drastically reducing the time and cost associated with initial research phases. By predicting failures earlier, these digital twins help prioritize more promising compounds for expensive human clinical testing.
Powered by AI • Not a substitute for human analysisMore Insights →
Share
Filed under:AI News
Comments
Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.